ロード中...
In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates
Objective: Ciprofloxacin resistance (CIP(R)) for Shigella isolates is becoming more prevalent. This study systematically investigated the antibacterial activity of ciprofloxacin (CIP)/fosfomycin (FOS) combination in vitro and in vivo against CIP(R) S. flexneri isolates. Method: Eighty CIP(R) S. flex...
保存先:
| 出版年: | Infect Drug Resist |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6580129/ https://ncbi.nlm.nih.gov/pubmed/31354311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S208071 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|